| The molecular taxonomy of primary prostate cancer A Abeshouse, J Ahn, R Akbani, A Ally, S Amin, CD Andry, M Annala, ... Cell 163 (4), 1011-1025, 2015 | 2815 | 2015 |
| Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer H Beltran, D Prandi, JM Mosquera, M Benelli, L Puca, J Cyrta, C Marotz, ... Nature medicine 22 (3), 298-305, 2016 | 1611 | 2016 |
| Punctuated evolution of prostate cancer genomes SC Baca, D Prandi, MS Lawrence, JM Mosquera, A Romanel, Y Drier, ... Cell 153 (3), 666-677, 2013 | 1483 | 2013 |
| Genomic correlates of clinical outcome in advanced prostate cancer W Abida, J Cyrta, G Heller, D Prandi, J Armenia, I Coleman, M Cieslik, ... Proceedings of the National Academy of Sciences 116 (23), 11428-11436, 2019 | 1201 | 2019 |
| SOX2 promotes lineage plasticity and antiandrogen resistance in TP53-and RB1-deficient prostate cancer P Mu, Z Zhang, M Benelli, WR Karthaus, E Hoover, CC Chen, ... Science 355 (6320), 84-88, 2017 | 1001 | 2017 |
| Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine C Pauli, BD Hopkins, D Prandi, R Shaw, T Fedrizzi, A Sboner, V Sailer, ... Cancer discovery 7 (5), 462-477, 2017 | 956 | 2017 |
| A highly specific SpCas9 variant is identified by in vivo screening in yeast A Casini, M Olivieri, G Petris, C Montagna, G Reginato, G Maule, ... Nature biotechnology 36 (3), 265-271, 2018 | 540 | 2018 |
| Tumor clone dynamics in lethal prostate cancer S Carreira, A Romanel, J Goodall, E Grist, R Ferraldeschi, S Miranda, ... Science translational medicine 6 (254), 254ra125-254ra125, 2014 | 402 | 2014 |
| Patient derived organoids to model rare prostate cancer phenotypes L Puca, R Bareja, D Prandi, R Shaw, M Benelli, WR Karthaus, J Hess, ... Nature communications 9 (1), 2404, 2018 | 338 | 2018 |
| Whole-exome sequencing of metastatic cancer and biomarkers of treatment response H Beltran, K Eng, JM Mosquera, A Sigaras, A Romanel, H Rennert, ... JAMA oncology 1 (4), 466-474, 2015 | 321 | 2015 |
| Clonal evolution of chemotherapy-resistant urothelial carcinoma BM Faltas, D Prandi, ST Tagawa, AM Molina, DM Nanus, C Sternberg, ... Nature genetics 48 (12), 1490-1499, 2016 | 300 | 2016 |
| A phase II trial of the aurora kinase a inhibitor alisertib for patients with castration-resistant and neuroendocrine prostate cancer: efficacy and biomarkers H Beltran, C Oromendia, DC Danila, B Montgomery, C Hoimes, ... Clinical Cancer Research 25 (1), 43-51, 2019 | 254 | 2019 |
| SPOP mutation leads to genomic instability in prostate cancer G Boysen, CE Barbieri, D Prandi, M Blattner, SS Chae, A Dahija, ... Elife 4, e09207, 2015 | 199 | 2015 |
| GPU computing for systems biology L Dematté, D Prandi Briefings in bioinformatics 11 (3), 323-333, 2010 | 173 | 2010 |
| Unraveling the clonal hierarchy of somatic genomic aberrations D Prandi, SC Baca, A Romanel, CE Barbieri, JM Mosquera, J Fontugne, ... Genome biology 15, 1-16, 2014 | 113 | 2014 |
| Role of specialized composition of SWI/SNF complexes in prostate cancer lineage plasticity J Cyrta, A Augspach, MR De Filippo, D Prandi, P Thienger, M Benelli, ... Nature communications 11 (1), 5549, 2020 | 109 | 2020 |
| Hit and go CAS9 delivered through a lentiviral based self-limiting circuit G Petris, A Casini, C Montagna, F Lorenzin, D Prandi, A Romanel, ... Nature communications 8 (1), 15334, 2017 | 109 | 2017 |
| Beta-binders for biological quantitative experiments P Degano, D Prandi, C Priami, P Quaglia Electronic Notes in Theoretical Computer Science 164 (3), 101-117, 2006 | 85 | 2006 |
| Formal analysis of BPMN via a translation into COWS D Prandi, P Quaglia, N Zannone International Conference on Coordination Languages and Models, 249-263, 2008 | 75 | 2008 |
| ASEQ: fast allele-specific studies from next-generation sequencing data A Romanel, S Lago, D Prandi, A Sboner, F Demichelis BMC medical genomics 8, 1-12, 2015 | 73 | 2015 |
Alessandro RomanelDepartment of Cellular, Computational and Integrative (CIBIO), University of Trento, ItalyEmail yang diverifikasi di unitn.it